Literature DB >> 25677286

Descemetorhexis for Fuchs' dystrophy.

Gregory Moloney1, U-Teng Chan2, Alex Hamilton3, Aida Mohd Zahidin4, John R Grigg3, Raj N Devasahayam5.   

Abstract

OBJECTIVE: To describe 2 cases of spontaneous corneal clearing after Descemetorhexis: 1 after iatrogenic trauma (Case 1) and 1 as an intentional surgical intervention for Fuchs endothelial dystrophy (Case 2).
METHODS: Retrospective case reports.
RESULTS: Full corneal clarity was observed to restore at approximately 1 month after surgery in both cases. Central endothelial cell counts were recorded as 753 and 731 cells/mm(2) in cases 1 and 2, respectively, at last follow-up. Best spectacle corrected visual acuity (BSCVA) at was 6/6 in both cases at 6 weeks and is retained at 9 months.
CONCLUSIONS: Selective Descemetorhexis may offer visual rehabilitation without the need for a graft in select cases of Fuchs endothelial dystrophy. Descemetopexy in anticipation of corneal clearing is a viable initial strategy in cases of iatrogenic Descemet trauma with detachment.
Copyright © 2015 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25677286     DOI: 10.1016/j.jcjo.2014.10.014

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  9 in total

1.  Association of the Gutta-Induced Microenvironment With Corneal Endothelial Cell Behavior and Demise in Fuchs Endothelial Corneal Dystrophy.

Authors:  Viridiana Kocaba; Kishore Reddy Katikireddy; Ilene Gipson; Marianne O Price; Francis W Price; Ula V Jurkunas
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

2.  [Descemetectomy : An alternative to transplantation?]

Authors:  E L Bramann; K Schröder; S Schrader; G Geerling
Journal:  Ophthalmologe       Date:  2017-07       Impact factor: 1.059

3.  DMEK Calling.

Authors:  Alfonso Vasquez Perez; Mehran Zarei-Ghanavati; Christopher Liu
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

4.  A Historical Perspective on Treatment of Fuchs' Endothelial Dystrophy: We have Come a Long Way.

Authors:  Majid Moshirfar; Yanning Ding; Tirth J Shah
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep

Review 5.  Towards Clinical Trials in Fuchs Endothelial Corneal Dystrophy: Classification and Outcome Measures-The Bowman Club Lecture 2019.

Authors:  Sanjay V Patel
Journal:  BMJ Open Ophthalmol       Date:  2019-07-11

6.  Preclinical testing of small diameter Descemet membrane endothelial keratoplasty grafts to increase tissue availability.

Authors:  Sorcha Ní Dhubhghaill; Alina Miron; Jessica T Lie; Isabel Dapena; Silke Oellerich; Gerrit R J Melles
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

Review 7.  Current Perspectives on Corneal Transplantation (Part 2).

Authors:  Yee Ling Wong; Siyin Liu; Andrew Walkden
Journal:  Clin Ophthalmol       Date:  2022-03-04

Review 8.  Regenerative medicine in Fuchs' endothelial corneal dystrophy.

Authors:  Amy E Yuan; Roberto Pineda
Journal:  Taiwan J Ophthalmol       Date:  2020-07-06

9.  The Rapid Transformation of Transplantation for Corneal Endothelial Diseases: An Evolution From Penetrating to Lamellar to Cellular Transplants.

Authors:  Jie Zhang; Dipika V Patel; Charles N J McGhee
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.